giapreza

Generic: angiotensin ii

Labeler: la jolla pharmaceutical company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name giapreza
Generic Name angiotensin ii
Labeler la jolla pharmaceutical company
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

angiotensin ii .5 mg/mL

Manufacturer
La Jolla Pharmaceutical Company

Identifiers & Regulatory

Product NDC 68547-005
Product ID 68547-005_49438c9b-3fce-4f3b-b878-18a17bc62b2e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA209360
Listing Expiration 2026-12-31
Marketing Start 2022-09-15

Pharmacologic Class

Established (EPC)
vasoconstrictor [epc]
Physiologic Effect
vasoconstriction [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68547005
Hyphenated Format 68547-005

Supplemental Identifiers

RxCUI
1999007 1999012 2611704 2611707
UPC
0368547501023
UNII
M089EFU921
NUI
N0000192562 N0000009908

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name giapreza (source: ndc)
Generic Name angiotensin ii (source: ndc)
Application Number NDA209360 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01) / 1 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

angiotensin ii (.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "49438c9b-3fce-4f3b-b878-18a17bc62b2e", "openfda": {"nui": ["N0000192562", "N0000009908"], "upc": ["0368547501023"], "unii": ["M089EFU921"], "rxcui": ["1999007", "1999012", "2611704", "2611707"], "spl_set_id": ["c265d69a-3efe-4107-9a9e-e6fd3d531c48"], "pharm_class_pe": ["Vasoconstriction [PE]"], "pharm_class_epc": ["Vasoconstrictor [EPC]"], "manufacturer_name": ["La Jolla Pharmaceutical Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68547-005-01", "marketing_start_date": "20220915"}], "brand_name": "Giapreza", "product_id": "68547-005_49438c9b-3fce-4f3b-b878-18a17bc62b2e", "dosage_form": "INJECTION", "pharm_class": ["Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "68547-005", "generic_name": "angiotensin II", "labeler_name": "La Jolla Pharmaceutical Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Giapreza", "active_ingredients": [{"name": "ANGIOTENSIN II", "strength": ".5 mg/mL"}], "application_number": "NDA209360", "marketing_category": "NDA", "marketing_start_date": "20220915", "listing_expiration_date": "20261231"}